Matches 301 - 350 out of 395 < 1 2 3 4 5 6 7 8 >


Match Document Document Title
US20060159752 Extended release matrix tablets  
The present invention relates to extended release matrix tablets for oral administration that include a cationic polymer, a water-swellable polymer, and an alginic acid derivative to cause the...
US20110166101 MICROPARTICLES  
A substantially porous, micro-particle comprising therapeutically effective amounts of tretinoin and ethyl cellulose
US20140186415 POLYMER COMPOSITION AND POLYMER MATERIAL  
A polymer composition including a polymer having a hydroxyl group and a histidine or a histidine derivative grafted to the polymer having a hydroxyl group. A polymer material is also provided,...
US20090041743 SPERM-BLOCKING AGENT COMPOSITION WITH CONTRACEPTIVE EFFECT  
A sperm-blocking agent is disclosed. The composition comprises an aqueous solvent a gum which is a polysaccharide having about 0.3 to 10 wt % of the composition, wherein the polysaccharide is...
US20080161266 Ophthalmic Alginate Composition Related Methods of Manufacture and Methods of Use  
The present invention is directed to an ophthalmic composition comprising alginate having a minimum of about 0% and a maximum of about 50% guluronic units bound to an adjacent guluronic unit as a...
US20070092582 Methods of preserving ophthalmic solutions and preserved ophthalmic solutions  
A preservative system for aqueous ophthalmic solutions is provided, where the preservative system comprises a hydrogen peroxide source, at least one hydrogen peroxide stabilizer and an alkali...
US20080008738 Flexible bioresorbable hemostatic packing and stent  
The invention provides a flexible bioresorbable foam having hemostatic properties. The foam is formed from a carboxymethylcellulose suspension.
US20050272697 Composition and method for treating post-surgical pain  
A composition for reducing pain at a surgical wound site or trauma site comprising oxidized regenerated cellulose and a non-steroidal anti-inflammatory drug or pharmaceutically acceptable salt or...
US20060073203 Dry polymer and lipid composition  
The present invention provides an orally administrable composition comprising a dry mixture of polymer, lipid and bioactive agent, being capable on contact with water or GI tract liquid of forming...
US20060127473 Compositions and methods for stabilizing active pharmaceutical ingredients  
The present invention relates to stable pharmaceutical compositions having an unstable active pharmaceutical ingredient.
US20060052340 Ophthalmic solution  
It is an object of the present invention to provide an ophthalmic solution, which provides an enhanced comfort by suitably exhibiting an moisturizing effect to an eye and advantageously preventing...
US20060153909 Hard capsule  
The present invention is directed to a hard capsule filled with a solution containing an active ingredient, characterized in that the solution contains an inorganic chloride and has a water...
US20060210625 Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms  
An oral pharmaceutical composition, comprising one or more positively charged, highly water-soluble pharmaceutically active agents such as trospium chloride, and one or more polymers containing...
US20120253298 LAYERED TISSUE THICKNESS COMPENSATOR  
A tissue thickness compensator may generally comprise a first layer comprising a first medicament, a second layer comprising a second medicament, and a third layer comprising a third medicament....
US20100092419 MAGNETIC FLUIDS AND THEIR USE  
Disclosed are magnetic fluids containing ionic liquids and containing no stabilisation agents or containing selected stabilisation agents. These magnetic fluids can be used in different fields of...
US20050214368 Controlled release formulations using intelligent polymers  
A controlled release pharmaceutical composition comprises (a) at least one pharmaceutically active substance having a water contact angle (θ) such that cos θ is between +0.9848 and −0.9848, (b) a...
US20050215516 New free-radical scavenger containing viscoelastic composition, methods of use and package  
The present invention is directed to a viscoelastic composition comprising an aqueous solution having a minimum of about 0.01% w/v and a maximum of about 20% w/v of a viscoelastic polymer based...
US20080113935 Use of lipid conjugates in the treatment of diseases or disorders of the eye  
In one embodiment, the invention provides a method of treating, reducing the incidence, reducing the severity or pathogenesis of an eye disease or disorder in a subject, including, inter alia,...
US20150216808 NON-DIGESTIBLE CAPSULES FOR THE DELIVERY OF FLUID ABSORBING MATERIALS  
The invention relates to a product, method of use, and/or method of preparing a capsule or capsular like product that comprises hydrophilic fluid-absorbing materials that bind, entrap, and/or...
US20120177719 MEDICAL DEVICE INTENDED TO COME INTO CONTACT WITH A PATIENT'S TISSUE AND RELATED MANUFACTURING METHOD  
A device including a body (12) including fibers without oxidized cellulose. The body (12) also includes fibers containing oxidized cellulose.
US20070134330 Methods and compositions for improved image quality  
The present invention is directed to consumable coating compositions for use on consumable products, such as pharmaceutical products (e.g., tablets, pills, capsule, gel cap, caplet).
US20050260153 Facilitation of iontophoresis using charged moieties  
The invention provides compositions and methods for making and using sterically enhanced antagonist aptamer conjugates that include a nucleic acid sequence having a specific affinity for a target...
US20070104787 Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances  
Disclosed herein are pharmaceutical compositions comprising carboxyalkylcellulose esters for sustained delivery of pharmaceutically active substances. The composition comprises: at least one...
US20070167402 Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same  
The present invention provides a coprecipitate of 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5 H), 10-dio xo-2H-1,2,3-triazolo[4,5-c][1]benzazepine and a water-soluble polymer,...
US20110111035 INFLAMMATION-REGULATING COMPOSITIONS AND METHODS  
The various embodiments provide a composition that provides local control over inflammation. The composition localizes the activities of the cytokine-neutralizing antibodies to the site of...
US20140076345 CLEANSING COMPOSITION FOR SKIN OR HAIR  
Provided is a cleansing composition for skin or hair capable of bringing about a good rinse feel and, in regard to hair, imparting softness to hair during rinsing and after towel drying, and...
US20140120169 DEVICE AND METHOD FOR ENCAPSULATION OF HYDROPHILIC MATERIALS  
A process for preparing polymeric composite particles includes the steps of preparing an oil phase containing a biodegradable polymer and a water phase containing a hydrophilic compound or...
US20150224223 SILVER CONTAINING WOUND DRESSING  
A wound dressing having anti-microbial activity comprises a first fibre capable of bonding with silver (1) cations. The wound dressing comprises a blend of the first fibre to which silver (1)...
US20140256676 SILVER CONTAINING WOUND DRESSING  
A wound dressing having anti-microbial activity comprises a first fibre capable of bonding with silver (1) cations. The wound dressing comprises a blend of the first fibre to which silver (1)...
US20130217649 SILVER CONTAINING WOUND DRESSING  
A wound dressing having anti-microbial activity comprises a first fibre capable of bonding with silver (1) cations. The wound dressing comprises a blend of the first fibre to which silver (1)...
US20060159751 Controlled release pharmaceutical compositions of carbidopa and levodopa  
The present invention relates to controlled release pharmaceutical compositions of carbidopa and levodopa that include a combination of different molecular weight cellulose ethers and in...
US20100184664 OPHTHALMIC COMPOSITIONS USEFUL FOR IMPROVING VISUAL ACUITY  
The present invention provides a method of improving the visual acuity of a person in need thereof which comprises topically administering to said person, in an effective amount, an ophthalmic...
US20050176679 Process for the preparation of free flowing pulverized adsorbates of tibolone  
The present invention concerns a process for the preparation of adsorbates and solvates of tibolone where one starts with a solution of tibolone or one of its solvates and/or one of its...
US20150072946 PROCESS FOR THE PREPARATION OF POLYSACCHARIDE NANOPARTICLES  
A process for the preparation of nanoparticles from polysaccharides and derivatives thereof, by their specific partial oxidation to produce aldehyde groups and attachment of compounds with amino...
US20100144669 DISSOLUTION AND PROCESSING OF CELLULOSE  
The invention relates to a method for dissolving the components of gel forming materials suitable for use in wound care comprising the steps of admixing said components with an ionic liquid. The...
US20060204577 Pharmaceutical Compositions of Drugs and Neutralized Acidic Polymers  
Pharmaceutical compositions comprised of low-solubility and/or acid-sensitive drugs and neutralized acidic polymers are disclosed.
US20090176735 PREVENTING OR REDUCING OXIDATIVE STRESS OR OXIDATIVE CELL INJURY  
A water-soluble cellulose derivative is useful for preventing or reducing oxidative stress or oxidative cell injury in tissues of an animal and in particular for regulating Stearoyl-CoA...
US20110217249 Compositions and Methods for the Treatment of Skin Diseases and Disorders Using Antimicrobial Peptide Sequestering Compounds  
The present invention provides compositions containing one or more antimicrobial peptide sequestering compounds and methods for topical application of such compositions to the skin to treat skin...
US20050256082 Allergen inactivator  
This invention relates to an allergen inactivating agent containing a polysaccharide derivative as its effective component, wherein said polysaccharide derivative has a cellulose ether or a starch...
US20120251482 USE FOR IMPROVING 5-HT FUNCTION AND ENOS EXPRESSION OF KMUPS AMINE SALTS  
The synthesized piperazium salt of KMUPs disclosed in the present invention is characterized by presented pharmaceutics having functions to improve 5-HT function and eNOS expression of KMUPS in...
US20090035350 Polymers for implantable devices exhibiting shape-memory effects  
The present invention is directed to polymeric compositions comprising a biodegradable copolymer that possesses shape-memory properties and implantable devices (e.g., drug-delivery stents) formed...
US20150080297 PEDIATRIC FIBER MIXTURE  
The present invention relates to a liquid nutritional composition for paediatric patients comprising beta-galacto-oligosaccharides, fructan, non-digestible alpha-glucan and hemicellulose.
US20120238524 WATER-SOLUBLE POLYSACCHARIDE ETHERS AND THEIR USE  
The invention relates to modified polysaccharide ethers having a weight-averaged molecular weight of 40000 to 50000 g/mole, zero shear viscosity of more than 10 Pas, and pseudoplasticity of more...
US20100317573 PEDIATRIC FIBER MIXTURE  
The present invention relates to a liquid nutritional composition for paediatric patients comprising beta-galacto-oligosaccharides, fructan, non-digestible alpha-glucan and hemicellulose.
US20050197319 Allergen inactivating agent  
An allergen inactivating agent is provided which has no adverse effects on the human body and which does not cause problems such as color development. An allergen inactivating agent containing a...
US20050215515 Viscoelastic composition, method of use and package  
The present invention is a viscoelastic composition, methods of use and a related device, wherein the viscoelastic composition comprises water, a minimum of about 0.01% w/v and a maximum of about...
US20080069857 Compositions And Methods For Inhibiting Adhesions  
The present invention provides compositions and methods for inhibiting adhesions. The methods involve administering solutions containing hydrogel precursors such as polysaccharide derivatives,...
US20100298264 BIODEGRADABLE AND WATER-SOLUBLE HEMOSTATIC MATERIAL AND A METHOD FOR PREPARING THE SAME  
A biodegradable and water-soluble hemostatic material is provided. The hemostatic material comprises an oxidized regenerated cellulose salt having a degree of carboxylic acid oxidation not less...
US20100260839 AQUEOUS FILM COATING SOLUTION, FILM COATED GRANULE AND TABLET USING THE SAME  
An object of the present invention is to provide an aqueous film coating solution, and the like, which has good acid resistance and sustained release properties as well as the flexibility suitable...
US20100279982 CELLULOSE DERIVATIVE  
A cellulose derivative which has a suitable elastic modulus and viscosity when it is dissolved in water and is useful as an adhesion barrier. The cellulose derivative has a molecular weight of...

Matches 301 - 350 out of 395 < 1 2 3 4 5 6 7 8 >